Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials

Abstract Introduction Prurigo nodularis (PN) is a dermatological condition characterized by intensely itchy nodules. The Prurigo Activity and Severity (PAS) assessment tool is a clinician-reported questionnaire used in the phase 3 dupilumab trials. Methods This post hoc analysis of pooled data from...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Sonja Stander, Claudia Zeidler, Jerome Msihid, Melanie Makhija, Ashish Bansal, Simmi Wiggins, Joseph Zahn, Ryan B. Thomas, Donia Bahloul
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Adis, Springer Healthcare 2026-04-01
श्रृंखला:	Dermatology and Therapy
विषय:	Prurigo nodularis Prurigo activity and severity score Dupilumab Responder rates
ऑनलाइन पहुंच:	https://doi.org/10.1007/s13555-026-01692-3
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!